| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |